J.L. Vermilion

1.3k citations
9 papers · 1.1k indexed · h-index 7
Topics
Pharmacogenetics and Drug Metabolism (5 papers)Cholesterol and Lipid Metabolism (4 papers)Drug Transport and Resistance Mechanisms (3 papers)
Partner nations
United States

In The Last Decade

J.L. Vermilion

9 papers receiving 1.0k citations

Peers

J.L. Vermilion
Comparison fields: 5 of 77
  • Molecular Biology 566
  • Pharmacology 537
  • Oncology 276
  • Biochemistry 166
  • Surgery 138
Replace Y. Yasukochi with:
Y. Yasukochi Japan
Kenneth C. Leibman United States
T D Porter United States
Peter Hlavica Germany
K Ruckpaul Germany
Eugene G. Hrycay Canada
Sylvie Dijols France
J.A. Peterson United States
Dieter Schwarz Germany
Bruce A. Mico United States
J.L. Vermilion relative to Y. Yasukochi Japan Y. Yasukochi's profile →
Citations per field
00.5×
Y. Yasukochi · 1×
Citations per year

Countries citing papers authored by J.L. Vermilion

Since Specialization
Citations

This map shows the geographic impact of J.L. Vermilion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Vermilion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Vermilion more than expected).

Fields of papers citing papers by J.L. Vermilion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.L. Vermilion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Vermilion. The network helps show where J.L. Vermilion may publish in the future.

Co-authorship network of co-authors of J.L. Vermilion

This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Vermilion. A scholar is included among the top collaborators of J.L. Vermilion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Vermilion. J.L. Vermilion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 4
2 81
3 31
4 246
5 308
6 196
7 3
8 148
9 64

About J.L. Vermilion

J.L. Vermilion is a scholar working on Pharmacology, Clinical Biochemistry and Biochemistry, having authored 9 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Cholesterol and Lipid Metabolism (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Pharmacology (537 citations), Biochemistry (166 citations) and Oncology (276 citations). J.L. Vermilion has collaborated with scholars based in United States. Frequent co-authors include Minor J. Coon, David P. Ballou, Vincent Massey, George J. Schroepfer, Jan St. Pyrek, William K. Wilson, T.W. Stephens, Joseph A. Martin, Barry N. Lutsky and Hong-Seok Kim. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Advances in experimental medicine and biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026